WO2000066749A1 - Acyltransferases de plantes - Google Patents
Acyltransferases de plantesInfo
- Publication number
- WO2000066749A1 WO2000066749A1 PCT/US2000/012316 US0012316W WO0066749A1 WO 2000066749 A1 WO2000066749 A1 WO 2000066749A1 US 0012316 W US0012316 W US 0012316W WO 0066749 A1 WO0066749 A1 WO 0066749A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- seq
- plant
- nucleotide sequence
- fragment
- Prior art date
Links
- 108700016155 Acyl transferases Proteins 0.000 title description 13
- 108700014220 acyltransferase activity proteins Proteins 0.000 title description 2
- 102000045404 acyltransferase activity proteins Human genes 0.000 title 1
- 241000196324 Embryophyta Species 0.000 claims abstract description 83
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 claims abstract description 10
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 claims abstract description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 84
- 102000039446 nucleic acids Human genes 0.000 claims description 80
- 108020004707 nucleic acids Proteins 0.000 claims description 80
- 239000002773 nucleotide Substances 0.000 claims description 56
- 125000003729 nucleotide group Chemical group 0.000 claims description 56
- 239000012634 fragment Substances 0.000 claims description 26
- 229920001184 polypeptide Polymers 0.000 claims description 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
- 230000009261 transgenic effect Effects 0.000 claims description 14
- 230000000692 anti-sense effect Effects 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 241000219198 Brassica Species 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 36
- 108090000623 proteins and genes Proteins 0.000 abstract description 31
- 240000002791 Brassica napus Species 0.000 abstract description 14
- 235000011293 Brassica napus Nutrition 0.000 abstract description 3
- 239000003921 oil Substances 0.000 description 57
- 235000019198 oils Nutrition 0.000 description 56
- 101100499137 Arabidopsis thaliana DGAT1 gene Proteins 0.000 description 36
- 101100008883 Oryza sativa subsp. japonica DGAT1-1 gene Proteins 0.000 description 36
- 239000013615 primer Substances 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 102000057234 Acyl transferases Human genes 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 108090000994 Catalytic RNA Proteins 0.000 description 7
- 102000053642 Catalytic RNA Human genes 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 239000000470 constituent Substances 0.000 description 7
- 108091092562 ribozyme Proteins 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 235000011331 Brassica Nutrition 0.000 description 5
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 5
- 101710190853 Cruciferin Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000010779 crude oil Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 4
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 4
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000251131 Sphyrna Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 244000060924 Brassica campestris Species 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- -1 Vol. 2 Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 150000001982 diacylglycerols Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001030 gas--liquid chromatography Methods 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 238000012226 gene silencing method Methods 0.000 description 2
- 125000004383 glucosinolate group Chemical group 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 102100031251 1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 Human genes 0.000 description 1
- NUKQEEMKQGMUQH-UHFFFAOYSA-N 1-methyl-1-nitrosoguanidine Chemical compound O=NN(C)C(N)=N NUKQEEMKQGMUQH-UHFFFAOYSA-N 0.000 description 1
- 108010054662 2-acylglycerophosphate acyltransferase Proteins 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 235000003901 Crambe Nutrition 0.000 description 1
- 241000220246 Crambe <angiosperm> Species 0.000 description 1
- 102100027819 Cytosolic beta-glucosidase Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101710088335 Diacylglycerol acyltransferase/mycolyltransferase Ag85A Proteins 0.000 description 1
- 101710088334 Diacylglycerol acyltransferase/mycolyltransferase Ag85B Proteins 0.000 description 1
- 101710088427 Diacylglycerol acyltransferase/mycolyltransferase Ag85C Proteins 0.000 description 1
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 1
- 108010093099 Endoribonucleases Proteins 0.000 description 1
- 102000002494 Endoribonucleases Human genes 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 101710091951 Glycerol-3-phosphate acyltransferase Proteins 0.000 description 1
- 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
- 101000859692 Homo sapiens Cytosolic beta-glucosidase Proteins 0.000 description 1
- 101000997662 Homo sapiens Lysosomal acid glucosylceramidase Proteins 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 101710089395 Oleosin Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 description 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000248384 Tetrahymena thermophila Species 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 150000002313 glycerolipids Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Definitions
- the invention relates to alteration of oil content in plants.
- Triacylglycerols produced in plant tissues are a significant source of fatty acids in the human diet. Diets rich in animal fat appear to promote maladies such as heart disease in humans. The ability to modulate triacyl glycerol synthesis in plants could allow for production of fatty acid compositions that are more beneficial for humans or more efficiently synthesized by the plant. Cloning and characterization of plant genes encoding enzymes involved in triacylglycerol synthesis and metabolism represents a major advance toward controlling triacylglycerol synthesis in plants.
- a new plant acyltransferase gene from Brassica napus has been cloned and characterized.
- the protein encoded by this gene is involved in triacylglycerol synthesis.
- Partial DNA sequences of the B. napus gene confirm that it is related to an Arabidopsis thaliana putative acyltransferase gene.
- Antisense expression of the B. napus sequence decreases total oil content.
- the invention features an isolated nucleic acid having at least 80% (e.g., 85%, 90%, or 99%) sequence identity to the nucleotide sequence of SEQ ID NO:3, or to a fragment of the nucleotide sequence of SEQ ID NO:3, the fragment being at least 15 nucleotides in length.
- An isolated nucleic acid having at least 80% (e.g., 85%, 90%, or 99%) sequence identity to the nucleotide sequence of SEQ ID NO:4, or to a fragment of the nucleotide sequence of SEQ ID NO:4, the fragment being at least 15 nucleotides in length is also featured.
- the invention features an isolated nucleic acid that includes a first and second region, the first region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:3 and the second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
- the nucleic acid can encode a diacylglycerol acyltransferase polypeptide.
- the first and second regions can be separated by approximately 600 nucleotides.
- the nucleic acid can be the insert of pMB143.
- An expression vector including the nucleic acid operably linked to an expression control element also is featured.
- the nucleic acid can be operably linked in antisense orientation.
- the invention features a transgenic plant and progeny thereof that include an exogenous nucleic acid encoding a diacylglycerol acyltransferase polypeptide operably linked to a regulatory element, and seed produced by such plants.
- the nucleic acid can include a first and second region, the first region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:3, the second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
- the transgenic plant can produce seeds that exhibit a statistically significantly altered oil content as compared to seeds produced by a corresponding plant lacking the nucleic acid encoding the diacylglycerol acyltransferase polypeptide.
- the plant can be a soybean plant or a Brassica plant.
- the invention also features a nucleic acid that includes the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4 or the nucleotide sequence exactly complementary to SEQ ID NO:3 or SEQ ID NO:4.
- the nucleic acid also can include the RNA equivalent of the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, or an RNA equivalent that is exactly complementary to the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4.
- the nucleotide sequences of SEQ ID NO:3 and SEQ ID NO:4 are partial sequences of the new B. napus gene.
- the invention features a nucleic acid that (1) hybridizes under stringent conditions to a DNA molecule consisting of the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, and (2) encodes a plant acyltransferase.
- the invention includes a nucleic acid (1 ) having a nucleotide sequence which is at least 80% (e.g., at least 82, 85, 90, 92, 95, 98, or 99%) identical to the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4, and (2) encoding a plant acyltransferase.
- the term "stringent conditions” means hybridization at 42°C in the presence of 50% formamide; a first wash at 65°C with 2X SSC containing 1% SDS; followed by a second wash at 65°C with 0.1 X SSC.
- the nucleotide sequence fragments described below can be used to hybridize against cD A or genomic DNA libraries from a variety of sources to clone genes related to the B. napus acyltransferase gene.
- the sequence fragments can be used to design additional primers for further sequencing of the B. napus gene or for PCR amplification of portions of the B. napus gene.
- Figure 1 is a schematic of a construct containing the acyltransferase. Restriction sites are marked.
- Figure 2 is a schematic of a construct containing the acyltransferase in antisense orientation. Restriction sites are marked.
- Triacylglycerols are synthesized by the sequential transfer of acyl chains to the glycerol backbone by a series of enzymes in the Kennedy pathway (glycerol-3-phosphate acyltransferase, lysophosphatidic acid acyltransferase, and diacylglycerol acyltransferase). See, Topfer et al., Science. 1995, 268:681-686. Diacylglycerol can be used to form TAGs or membrane glycerolipids, and is the substrate for diacylglycerol acyltransferase (DAGAT, E.C. 2.3.1.20).
- DAAT diacylglycerol acyltransferase
- DAGAT transfers a third acyl chain to diacylglycerol, forming a TAG, and is the only enzyme unique to TAG synthesis in the Kennedy pathway.
- the reaction catalyzed by DAGAT represents a key branchpoint in TAG synthesis.
- a 1.4 kB gene that encodes DAGAT has been identified from Brassica and can be used to alter total oil content in plants.
- the invention features isolated nucleic acids having at least 80% sequence identity, e.g., 85%, 90%, 95%, or 99% sequence identity, to the nucleic acid of SEQ ID NO:3 or SEQ ID NO:4, or fragments of the nucleic acid of SEQ ID NO:3 or 4 that are at least about 15 nucleotides (nt) in length (e.g., at least 18, 20, 22, 24, 26, 28, or 30 nt).
- the nucleic acid includes a first region having at least 80%) sequence identity to the nucleotide sequence of SEQ ID NO:3 and a second region having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO:4.
- the first and second regions can be separated by about 590 to about 700 nucleotides, e.g., about 600 nucleotides.
- percent sequence identity is calculated by determining the number of matched positions in aligned nucleic acid sequences, dividing the number of matched positions by the total number of aligned nucleotides, and multiplying by 100.
- a matched position refers to a position in which identical nucleotides occur at the same position in aligned nucleic acid sequences.
- the total number of aligned nucleotides refers to the number of nucleotides from SEQ ID NO:3 or NO:4 that are being aligned.
- Nucleic acid sequences can be aligned by the Clustal algorithm of MEGALIGN® (DNASTAR, Madison, WI, 1997) sequence alignment software. In this method, sequences are grouped into clusters by examining the distances between all pairs.
- Isolated nucleic acid molecules of the invention can be produced by standard techniques.
- isolated refers to a sequence corresponding to part or all of a gene encoding a DAGAT polypeptide, but free of sequences that normally flank one or both sides of the wild-type gene in a plant genome.
- polypeptide refers to a chain of least eight amino acids.
- An isolated nucleic acid can be, for example, a DNA molecule, provided one of the nucleic acid sequences normally found immediately flanking that DNA molecule in a naturally-occurring genome is removed or absent.
- an isolated nucleic acid includes, without limitation, a DNA molecule that exists as a separate molecule (e.g., a cDNA or genomic DNA fragment produced by PCR or restriction endonuclease treatment) independent of other sequences as well as recombinant DNA that is incorporated into a vector, an autonomously replicating plasmid, a virus (e.g., a retrovirus, adenovirus, or herpes virus), or into the genomic DNA of a prokaryote or eukaryote.
- an isolated nucleic acid can include a recombinant DNA molecule that is part of a hybrid or fusion nucleic acid.
- a nucleic acid existing among hundreds to millions of other nucleic acids within, for example, cDNA libraries or genomic libraries, or gel slices containing a genomic DNA restriction digest, is not to be considered an isolated nucleic acid.
- Isolated nucleic acid molecules are at least about 15 nucleotides in length.
- the nucleic acid molecule can be about 20 to 35, 40-50, 50-100, or greater than 150 nucleotides in length, e.g., 200-300, 300-500, 500-1000, or 1 100-1500 nucleotides in length.
- Such fragments, whether encoding a polypeptide or not, can be used as probes, primers, and diagnostic reagents.
- the isolated nucleic acid molecules encode a full-length DAGAT polypeptide.
- Nucleic acid molecules can be DNA or RNA, linear or circular, and in sense or antisense orientation.
- the nucleic acid molecules also can be complementary to the nucleotide sequences of SEQ ID NO:3 or SEQ ID NO:4.
- a nucleic acid encoding a DAGAT polypeptide may or may not contain introns within the coding sequence.
- PCR Polymerase chain reaction
- Nucleic acids encoding DAGAT polypeptides also can be produced by chemical synthesis, either as a single nucleic acid molecule or as a series of oligonucleotides. For example, one or more pairs of long oligonucleotides (e.g., >100 nucleotides) can be synthesized that contain the desired sequence, with each pair containing a short segment of complementarity (e.g., about 15 nucleotides) such that a duplex is formed when the oligonucleotide pair is annealed. DNA polymerase is used to extend the oligonucleotides, resulting in a double-stranded nucleic acid molecule per oligonucleotide pair, which then can be ligated into a vector.
- a short segment of complementarity e.g., about 15 nucleotides
- nucleic acids will encode a polypeptide having a particular DAGAT amino acid sequence.
- the degeneracy of the genetic code is well known in the art, i.e., many amino acids are encoded by more than one nucleotide codon.
- certain amino acid substitutions can be made within polypeptide sequences without affecting the function of the polypeptide.
- Conservative amino acid substitutions or substitutions of similar amino acids often are tolerated without affecting polypeptide function.
- Similar amino acids can be those that are similar in size and/or charge properties. Similarity between amino acids has been assessed in the art. For example, Dayhoff et al. (1978) in Atlas of Protein Sequence and Structure, Vol. 5, Suppl. 3, pp. 345-352, provides frequency tables for amino acid substitutions that can be employed as a measure of amino acid similarity.
- the invention features transgenic plants that have altered total oil content, i.e., increased or decreased oil content.
- Suitable plant species include, for example, Brassica spp. such as B. napus, B. campestris, B.juncea, and B. rapa (canola-type and high erucic acid rapeseed), soybean, sunflower, castor bean, safflower, crambe, palm, coconut, corn, cottonseed, olive, peanut, flax, and sesame.
- Canola, soy, sunflower, and safflower plants having increased oil content are particularly useful.
- Table 1 provides relative percent oil and protein content on a dry weight basis (unless indicated otherwise) of suitable oilseed plants.
- the present invention describes a novel method of making transgenic plants that produce seeds with a statistically significant alteration in oil content.
- "statistically significant” refers to a p-value of less than 0.05, e.g., a p-value of less than 0.025 or a p-value of less than 0.01, using an appropriate measure of statistical significance, e.g., a one-tailed two sample t-test.
- plants can be produced that exhibit an altered oil content in their seeds.
- the altered oil content is statistically significant relative to the oil content of unmodified seeds.
- Plants produced by the method of the present invention can produce seeds having an increase in oil of from about 1% to about 25% over the oil content in seeds produced by unmodified control plants.
- the increase in oil content for plants described herein can be from about 2% to about 20%, from about 4% to about 15%, from about 5% to about 10%, or from about 10% to about 20%, relative to unmodified plants.
- a plant described herein may be used as a parent to develop a plant line, or may itself be a member of a plant line, i.e., it is one of a group of plants that display little or no genetic variation between individuals for total oil content.
- Such lines can be created by several generations of self-pollination and selection, or vegetative propagation from a single parent using tissue or cell culture techniques known in the art. Additional means of breeding plant lines from a parent plant are known in the art.
- plants of the invention can be obtained by introducing at least one exogenous nucleic acid encoding a DAGAT polypeptide into plant cells.
- exogenous refers to a nucleic acid that is introduced into the plant. Exogenous nucleic acids include those that naturally occur in the plant and have been introduced to provide one or more additional copies, as well as nucleic acids that do not naturally occur in the plant.
- a nucleic acid construct containing a nucleic acid encoding a DAGAT polypeptide is introduced into a plant cell. Seeds produced by a transgenic plant can be grown and selfed (or outcrossed and selfed) to obtain plants homozygous for the construct.
- Transgenic plants can be entered into a breeding program, e.g., to increase seed, to introgress the novel construct into other lines or species, or for further selection of other desirable traits.
- transgenic plants can be obtained by vegetative propagation of a transformed plant cell, for those species amenable to such techniques.
- Progeny of a transgenic plant are included within the scope of the invention, provided that such progeny exhibit altered oil content.
- Progeny of an instant plant include, for example, seeds formed on Fi, F 2 , F 3 , and subsequent generation plants, or seeds formed on BCi, BC 2 , BC 3 , and subsequent generation plants.
- Transgenic techniques for use in the invention include, without limitation, Agrobacterium-mediated transformation, electroporation, and particle gun transformation.
- Illustrative examples of transformation techniques are described in WO 99/43202 and U.S. Patent 5,204,253 (particle gun) and U.S. Patent 5,188,958 (Agro bacterium). Transformation methods utilizing the Ti and Ri plasmids of Agrobacterium spp. typically use binary type vectors. Walkerpeach, C. et al., in Plant Molecular Biology Manual, S. Gelvin and R. Schilperoort, eds., Kluwer Dordrecht, Cl :l-19 (1994). If cell or tissue cultures are used as the recipient tissue for transformation, plants can be regenerated from transformed cultures by techniques known to those skilled in the art. In addition, various plant species can be transformed using the pollen tube pathway technique.
- Nucleic acid constructs suitable for producing transgenic plants of the invention include a nucleic acid encoding a DAGAT polypeptide operably linked to a regulatory element such as a promoter. Standard molecular biology techniques can be used to generate nucleic acid constructs. To increase oil content in plants, the nucleic acid encoding a DAGAT polypeptide is operably linked to the regulatory element in sense orientation. Suitable promoters can be constitutive or inducible, and can be seed-specific.
- constitutive promoter refers to a promoter that facilitates the expression of a nucleic acid molecule without significant tissue- or temporal- specificity.
- An inducible promoter may be considered to be a "constitutive promoter", provided that once induced, expression of the nucleic acid molecule is relatively constant or uniform without significant tissue- or temporal-specificity. Suitable promoters are known (e.g., Weising et al., Ann. Rev. Genetics 22:421-478 (1988)).
- promoters suitable for use herein regulatory sequences from fatty acid desaturase genes (e.g., Brassica fadlD or fad2F, see WO 00/07430); alcohol dehydrogenase promoter from corn; light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species; major chlorophyll a/b binding protein gene promoters; the 19S promoter of cauliflower mosaic virus (CaMV); as well as synthetic or other natural promoters that are either inducible or constitutive.
- regulatory sequences from fatty acid desaturase genes e.g., Brassica fadlD or fad2F, see WO 00/07430
- alcohol dehydrogenase promoter from corn
- light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species
- regulatory sequences are seed-specific, i.e., the particular gene product is preferentially expressed in developing seeds and expressed at low levels or not at all in the remaining tissues of the plant.
- seed-specific promoters include napin, phaseolin, oleosin, and cruciferin promoters.
- Additional regulatory elements may be useful in the nucleic acid constructs of the present invention, including, but not limited to, polyadenylation sequences, enhancers, introns, and the like. Such elements may not be necessary for expression of a DAGAT polypeptide, although they may increase expression by affecting transcription, stability of the mRNA, translational efficiency, or the like. Such elements can be included in a nucleic acid construct as desired to obtain optimal expression of the acyltransferase nucleic acid in the host cell(s). Sufficient expression, however, may sometimes be obtained without such additional elements.
- a reference describing specific regulatory elements is Weising et al., Ann. Rev. Genetics 22:421-478 (1988).
- a feature of the invention is that DAGAT activity can be reduced by gene silencing, antisense, ribozymes, cosuppression, or mutagenesis techniques, resulting in a decrease in oil content.
- Gene silencing techniques such as that described in WO 98/36083 are useful.
- Antisense RNA has been used to inhibit plant target genes in a tissue-specific manner. See, for example, U.S. Patent Nos. 5,453,566, 5,356,799, and 5,530,192.
- Antisense nucleic acid constructs include a partial or a full-length coding sequence operably linked to at least one suitable regulatory sequence in antisense orientation.
- DAGAT also can be inhibited by ribozyme molecules designed to cleave DAGAT mRNA transcripts. While various ribozymes that cleave mRNA at site-specific recognition sequences can be used to destroy DAGAT mRNAs, hammerhead ribozymes are particularly useful. Hammerhead ribozymes cleave mRNAs at locations dictated by flanking regions that form complementary base pairs with the target mRNA. The sole requirement is that the target RNA contain a 5'-UG- 3' nucleotide sequence. The construction and production of hammerhead ribozymes is well known in the art. See, for example, U.S. Patent No. 5,254,678.
- RNA endoribonucleases such as the one that occurs naturally in Tetrahymena thermophila, and which have been described extensively by Cech and collaborators also are useful.
- Mutagenesis can also be used to reduce acytltransferase activity in plants.
- Mutagenic agents can be used to induce random genetic mutations within a population of seeds or regenerable plant tissue. Suitable mutagenic agents include, for example, ethyl methyl sulfonate, methyl N-nitrosoguanidine, ethidium bromide, diepoxybutane, x-rays, UV rays, and other mutagens known in the art.
- the treated population, or a subsequent generation of that population is screened for reduced oil content or reduced DAGAT activity that results from the mutation.
- Mutations can be in any portion of a gene, including the coding region, introns, and regulatory elements, that render the resulting gene product non-functional or with reduced activity. Suitable types of mutations include, for example, insertions or deletions of nucleotides, and transitions or transversions in the wild-type coding sequence. Such mutations can lead to deletion or insertion of amino acids, and conservative or non-conservative amino acid substitutions in the corresponding gene product.
- Oils Techniques that are routinely practiced in the art can be used to extract, process, and analyze the oils produced by plants of the instant invention.
- plant seeds are cooked, pressed, and extracted to produce crude oil, which is then degummed, refined, bleached, and deodorized.
- techniques for crushing seed are known in the art.
- soybean seeds can be tempered by spraying them with water to raise the moisture content to, e.g., 8.5%, and flaked using a smooth roller with a gap setting of 0.23 to 0.27 mm.
- water may not be added prior to crushing.
- Application of heat deactivates enzymes, facilitates further cell rupturing, coalesces the oil droplets, and agglomerates protein particles, all of which facilitate the extraction process.
- the majority of the seed oil can be released by passage through a screw press. Cakes expelled from the screw press are then solvent extracted, e.g., with hexane, using a heat traced column.
- crude oil produced by the pressing operation can be passed through a settling tank with a slotted wire drainage top to remove the solids that are expressed with the oil during the pressing operation.
- the clarified oil can be passed through a plate and frame filter to remove any remaining fine solid particles. If desired, the oil recovered from the extraction process can be combined with the clarified oil to produce a blended crude oil.
- Degumming can be performed by addition of concentrated phosphoric acid to the crude oil to convert non-hydratable phosphatides to a hydratable form, and to chelate minor metals that are present. Gum is separated from the oil by centrifugation. The oil can be refined by addition of a sufficient amount of a sodium hydroxide solution to titrate all of the fatty acids and removing the soaps thus formed.
- Deodorization can be performed by heating the oil to 500°F (260°C) under vacuum, and slowly introducing steam into the oil at a rate of about 0.1 ml/minute/100 ml of oil. After about 30 minutes of sparging, the oil is allowed to cool under vacuum. The oil is typically transferred to a glass container and flushed with argon before being stored under refrigeration. If the amount of oil is limited, the oil can be placed under vacuum, e.g., in a Parr reactor and heated to 500°F for the same length of time that it would have been deodorized. This treatment improves the color of the oil and removes a majority of the volatile substances.
- Oil content can be measured by NMR using AOCS Method AM 2-93 and AOCS Recommended Practice AK 4-95 or by near infra-red reflectance spectroscopy (NIR) using AOCS Method AK 3-94 and AOCS Procedure AM 1-92.
- Oil composition can be analyzed by extracting fatty acids from bulk seed samples (e.g., at least 10 seeds). Fatty acid TAGs in the seed are hydrolyzed and converted to fatty acid methyl esters. Percentages of fatty acids typically are designated on a weight basis and refer to the percentage of the fatty acid methyl ester in comparison with the total fatty acid methyl esters in the sample being analyzed.
- Seeds having an altered fatty acid composition may be identified by techniques known to the skilled artisan, e.g., gas-liquid chromatography (GLC) analysis of a bulked seed sample, a single seed or a single half-seed.
- LLC gas-liquid chromatography
- Half-seed analysis is well known in the art to be useful because the viability of the embryo is maintained and thus those seeds having what appears to be a desired fatty acid profile may be planted to form the next generation.
- bulk seed analysis typically yields a more accurate representation of the fatty acid profile of a given genotype.
- Fatty acid composition can also be determined on larger samples, e.g., oil obtained by pilot plant or commercial scale refining, bleaching and deodorizing of endogenous oil in the seeds.
- the following examples are to be construed as merely illustrative of how one skilled in the art can make and use the DAGAT gene fragments, and does not limit the scope of the invention described in the claims.
- Example 1 Cloning of a Brassica Acyl Transferase: A mouse acyl CoA:diacylglycerol acyltransferase (DAGAT) gene was recently identified (Case et al., Proc Natl Acad Sci USA 95:13018-13023, 1998). The deduced mouse DAGAT amino acid sequence was used to search for similar plant sequences in GenBank and dbEST databases. The mouse DAGAT protein sequence aligned with significant sequence identity and similarity to a putative Arabidopsis thaliana acyl- CoA:cholesterol acyltransferase (ACAT; GenBank Accession No. 3135276, locus ATAC003058). However, upon aligning the A.
- ACAT Arabidopsis thaliana acyl- CoA:cholesterol acyltransferase
- the 5' DAGAT- 1 primer had the sequence caucaucaucauACTGCCATGGACAGGTGTGATTCTGCTTTTT TATCA (SEQ ID NO:l), and the 3' DAGATD2 primer had the sequence cuacuacuacuaCTAGAGACAGGGCAATGTAGAAAGTATGTA (SEQ ID NO:2).
- Lowercase sequences were used for cloning into the pAMPl vector (Gibco, BRL).
- PCR amplification using DAGAT- 1 and DAGAT-2 primers was carried out as follows.
- Each lOO ⁇ l PCR reaction mixture contained 50ng of genomic DNA, 200 ⁇ M of each dNTP, IX buffer B (Gibco BRL), 1 ⁇ M DAGAT- 1 primer, 1 ⁇ M DAGAT-2 primer, 3mM magnesium sulfate, and 2 ⁇ l Elongase enzyme (Gibco BRL).
- the reaction mixture was denatured at 94°C for 3 minutes, followed by 30 cycles of denaturation at 94°C for 1 minute, annealing at 50°C for 2 minutes, and extension at 72°C for 3 minutes. A final extension incubation was performed at 72°C for 10 minutes after cycling. Based on the sequence of A. thaliana genomic DNA in
- GenBank Accession No. 3135276, a 1369 bp fragment was expected to be amplified from Brassica.
- FIG. 1 contains a restriction map of the pAMPl vector containing the putative DAGAT fragment, which has been designated pMB143.
- the partial sequence of the 5' end using the T7 primer was ACTTGCATTGTGTGGCTGAAGTTGGTTTCTTACGCTCATACTAACTATGAC ATAAGAACCCTAGCTAATTCATCTGATAAGGTAAAAGAAGTGATATAATA TTGGTCACTTGCATTGTGTTTTACTATTTTGACCAGACACTGTTGAAAACT GTAGGCCAATCCTGAAGTCTCCTACTATGTTAGCTTGAAGAGCTTGGCGTA TTTCATGCTTGCTCCCACATTGTGTTATCAGGTAATCTGATGCGTCTTCTGC TAATTGTATCATACATTATCTTTCACTTGCAAAAGTTTCTTGTCTAAAACCT TGCGTCTTCGCTTTACCCAGCCGAGCTATCCACGTTCT (SEQ ID NO:3).
- the partial sequence of the 3' end using the Sp6 primer was ATC AATCTTGTCTTACTC A A AAATCATATTATGTTTACGTTANTAACCAAA ATTCATGTACGCACTGTCTACCTTTGTCAGTATTGGAGAATGTGGAATATG GTATGGTTCTCTTCTTGAACATCCCCTTCTTTTTATACAAAGCAGATTAA GAAAAGCTTATTGAGATCTTGTTTTTTCTAATAGCCTGTTCATAAATGGAT GGTTCGACATGTATACTTTCCGTGCCTTCGCAGAAATATACCGAAAGTGA GTGTAGTTAATTGCGATGATCGATATTTTTTTCTGTGCTTCATAAATTTA AC CCTCCACTCATTTTTTTCCAGGTACCCGCTATTATCCTTGCTTTCTTAGTCT CTGCAGTCTTTCATGAGGTATAATACATACTTTCTACATTGNCCCTGTCTC (SEQ ID NO:4).
- the sequence of the B. napus clone obtained using the T7 primer had an overall identity of 76.5% with the corresponding region of the A. thaliana gene, suggesting that the 1.4 kb cloned B. napus fragment encoded a protein that may be related to the A. thaliana DAGAT or ACAT.
- Plasmid pMB143 will be deposited with the American Type Culture Collection (ATCC), 10801 University Boulevard., Manassas, VA, 201 10-2209.
- ATCC American Type Culture Collection
- Antisense DAGAT The putative DAGAT genomic DNA cloned in pAMPl was excised with a Smal/SnaBl digestion. The putative DAGAT fragment was purified and inserted at the blunted, EcoRl site of pMBl 10 to generate pMBl 71. This construct contains cruciferin promoter and cruciferin termination sequences. The antisense orientation of the putative DAGAT insert in pMB171 was confirmed with restriction analysis.
- the cruciferin promoter/putative DAGAT/cruciferin termination cassette was released from pMB171 by partially digesting with Xbal and completely digesting with Xhol, and cloned into the Xhol/Xbal sites of pMOG800 to generate pMB 170.
- Figure 2 provides a diagram of pMB 170.
- the construct pMB 170 was used to transform Agrobacterium LBA4404.
- Oil, protein, chlorophyll, glucosinolate, oleic acid (18: 1 ), linoleic acid (18:2), and ⁇ -linolenic acid (18:3) content were determined in the T2 seed samples.
- Oil content was measured by NIR using a Foss NIR Systems model 6500 Feed and Forage Analyzer (Foss North America, Eden Prairie, MN) calibrated according to manufacturer's recommendations.
- Canola seed samples which represented wide ranges of the sample constituents listed above, were collected for calibration.
- Lab analysis results were determined using accepted methodology (i.e., oil, AOCS Method Ak 3-94; moisture, AOCS Method Ai 2-75; fatty acid, AOCS Method CE le-91 and AOCS Method CE 2-66; chlorophyll, AOCS Method CC 13D-55; protein, AOCS Method BA 4e-93; and glucosinolates, AOCS Method Ak 1-92). Instrument response also was measured for each sample. A calibration equation was calculated for each constituent by means of chemometrics. These equations are combined into one computer file and are used for prediction of the constituents contained in unknown canola samples. T2 seed samples containing unknown levels of the above constituents were prepared by removing foreign material from the sample.
- T2 seeds from each of the ten selected plants were planted, and a nickel size portion of the leaf tissue was taken from plants about 2.5 weeks post-germination.
- Tissue samples were dried in a food dehydrator at 135°C for 8-16 hours.
- DNA was isolated using the Qiagen Dneasy96 Plant Kit, and resuspended in 150 ⁇ l of buffer.
- PCR amplification was performed in a 20 ⁇ l volume containing IX PCR buffer containing 1.5mM MgCl 2 (Qiagen PCR Core Kit), 0.2mM dNTP, 0.5 units Taq polymerase (Qiagen), 0.5 ⁇ M cruciferen primer (5'-CTT TAT GGA TGA GCT TGA TTG AG-3', SEQ ID NO:5), and 0.5 ⁇ M acyltransferase primer (5'-CCG CTC TAG AGG GAT CCA AGC-3', SEQ ID NO:6), 0.4% sucrose, and 0.008% cresol.
- IX PCR buffer containing 1.5mM MgCl 2 (Qiagen PCR Core Kit), 0.2mM dNTP, 0.5 units Taq polymerase (Qiagen), 0.5 ⁇ M cruciferen primer (5'-CTT TAT GGA TGA GCT TGA TTG AG-3', SEQ ID NO:5), and 0.5 ⁇ M acyltransferase
- Amplification conditions included 30 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 1 minute. PCR products were analyzed 1.2% agarose gel electrophoresis. As indicated in Table 1, the selected plants tested positive for the transgene.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2372632A CA2372632C (fr) | 1999-05-04 | 2000-05-04 | Acyltransferases de plantes |
EP00928864A EP1173583A1 (fr) | 1999-05-04 | 2000-05-04 | Acyltransferases de plantes |
AU47034/00A AU784352B2 (en) | 1999-05-04 | 2000-05-04 | Plant acyltransferases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13241799P | 1999-05-04 | 1999-05-04 | |
US60/132,417 | 1999-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000066749A1 true WO2000066749A1 (fr) | 2000-11-09 |
Family
ID=22453962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/012316 WO2000066749A1 (fr) | 1999-05-04 | 2000-05-04 | Acyltransferases de plantes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1173583A1 (fr) |
AU (1) | AU784352B2 (fr) |
CA (1) | CA2372632C (fr) |
WO (1) | WO2000066749A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1543130A2 (fr) * | 2002-07-31 | 2005-06-22 | Monsanto Technology, LLC | Sequences d'acides nucleiques de la diacylglycerol acyltransferase et produits associes |
EP1587359A2 (fr) * | 2003-01-08 | 2005-10-26 | Delta And Pine Land Company | Suppression de l'huile de graine servant a accroitre le rendement de macromolecules d'interet commercial |
US7045326B2 (en) | 2001-02-23 | 2006-05-16 | The Regents Of The University Of California | Mono- and diacylglycerol acyltransferases and methods of use thereof |
WO2009143401A3 (fr) * | 2008-05-23 | 2010-03-11 | E. I. Du Pont De Nemours And Company | Gènes dgat issus d'organismes oléagineux permettant une production accrue des lipides stockés dans les graines et une modification des profils d'acides gras dans les plantes oléagineuses |
US7862819B2 (en) | 2001-02-23 | 2011-01-04 | The J. David Gladstone Institutes | Diacylglycerol O-acyltransferase 2α (DGAT2α) |
US8716555B2 (en) | 2008-07-21 | 2014-05-06 | Commonwealth Scientific And Industrial Research Organisation | Cottonseed oil and uses |
US8735111B2 (en) | 2011-12-27 | 2014-05-27 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing hydrocarbon products |
US8809026B2 (en) | 2011-12-27 | 2014-08-19 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US8921652B2 (en) | 2008-07-21 | 2014-12-30 | Commonwealth Scientific And Industrial Research Organisation | Vegetable oils and uses therefor |
US9127288B2 (en) | 2010-06-28 | 2015-09-08 | Commonwealth Scientific And Industrial Research Organisation | Methods of producing lipids |
US9351507B2 (en) | 2006-07-14 | 2016-05-31 | Commonwealth Scientific And Industrial Research Organisation | Method of preparing food using rice oil |
US10323209B2 (en) | 2012-04-25 | 2019-06-18 | Commonwealth Scientific And Industrial Research Organisation | High oleic acid oils |
US10472587B2 (en) | 2014-07-07 | 2019-11-12 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing industrial products from plant lipids |
US11639507B2 (en) | 2011-12-27 | 2023-05-02 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US11859193B2 (en) | 2016-09-02 | 2024-01-02 | Nuseed Global Innovation Ltd. | Plants with modified traits |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2547320C (fr) * | 2003-11-25 | 2013-07-16 | National Research Council Of Canada | Genes elongase d'acide gras (fae) et leur utilite dans l'augmentation de l'acide erucique et autres proportions d'acide gras a tres longue chaine dans l'huile de graines |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055632A1 (fr) * | 1997-06-05 | 1998-12-10 | Calgene Llc | Acyle gras-coa: alcool gras acyltransferase |
WO1998055631A1 (fr) * | 1997-06-05 | 1998-12-10 | Calgene Llc | Proteines diacylglycerol acyltransferase |
WO1999063096A2 (fr) * | 1998-06-05 | 1999-12-09 | Calgene Llc | Acyl coa : sequences d'acide nucleique en rapport avec la cholesterol acyltransferase |
WO1999067268A1 (fr) * | 1998-06-24 | 1999-12-29 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
WO1999067403A1 (fr) * | 1998-06-24 | 1999-12-29 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
WO2000001713A2 (fr) * | 1998-07-02 | 2000-01-13 | Calgene Llc | Proteines de diacylglycerol acyl transferase |
WO2000032793A2 (fr) * | 1998-12-04 | 2000-06-08 | Calgene Llc | Diacylglycerol acyle transferases |
WO2000032756A2 (fr) * | 1998-12-02 | 2000-06-08 | E.I. Du Pont De Nemours And Company | Des diacylglycerol acyltransfease vegetale |
WO2000036114A1 (fr) * | 1998-12-17 | 2000-06-22 | National Research Council Of Canada | Gene de la diacylglycerol acyltransferase d'origine vegetale |
-
2000
- 2000-05-04 CA CA2372632A patent/CA2372632C/fr not_active Expired - Fee Related
- 2000-05-04 WO PCT/US2000/012316 patent/WO2000066749A1/fr active Application Filing
- 2000-05-04 AU AU47034/00A patent/AU784352B2/en not_active Ceased
- 2000-05-04 EP EP00928864A patent/EP1173583A1/fr not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055632A1 (fr) * | 1997-06-05 | 1998-12-10 | Calgene Llc | Acyle gras-coa: alcool gras acyltransferase |
WO1998055631A1 (fr) * | 1997-06-05 | 1998-12-10 | Calgene Llc | Proteines diacylglycerol acyltransferase |
WO1999063096A2 (fr) * | 1998-06-05 | 1999-12-09 | Calgene Llc | Acyl coa : sequences d'acide nucleique en rapport avec la cholesterol acyltransferase |
WO1999067268A1 (fr) * | 1998-06-24 | 1999-12-29 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
WO1999067403A1 (fr) * | 1998-06-24 | 1999-12-29 | The Regents Of The University Of California | Diacylglycerol o-acyltransferase |
WO2000001713A2 (fr) * | 1998-07-02 | 2000-01-13 | Calgene Llc | Proteines de diacylglycerol acyl transferase |
WO2000032756A2 (fr) * | 1998-12-02 | 2000-06-08 | E.I. Du Pont De Nemours And Company | Des diacylglycerol acyltransfease vegetale |
WO2000032793A2 (fr) * | 1998-12-04 | 2000-06-08 | Calgene Llc | Diacylglycerol acyle transferases |
WO2000036114A1 (fr) * | 1998-12-17 | 2000-06-22 | National Research Council Of Canada | Gene de la diacylglycerol acyltransferase d'origine vegetale |
Non-Patent Citations (27)
Title |
---|
CASES S ET AL: "Identification of a gene encoding an acyl CoA: diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 95, no. 22, 27 October 1998 (1998-10-27), pages 13018 - 13023, XP002122745, ISSN: 0027-8424 * |
CORY L. NYKIFORUK, ET AL.: "Isolation and Characterization of a cDNA Encoding a Second Putative Diacylglycerol Acyltransferase from a Microspore-derived Cell Suspension Culture of Brassica napus L. cv Jet Neuf (Accession No. AF164434).", PGR99-158) PLANT PHYSIOL. 121: 1057, 1999, XP002148237 * |
CORY L. NYKIFORUK, ET AL.: "ISOLATION AND SEQUENCE ANALYSIS OF A NOVEL CDNA ENCODING A PUTATIVE DIACYLGLYCEROL ACYLTRANSFERASE FROM A MICROSPORE-DERIVED CELL SUSPENSION CULTURE OF BRASSICA NAPUS L. CV JET NEUF (ACCESSION NO. AF155224).", (PGR99-123) PLANT PHYSIOL. 120: 1207, 1999, XP002148236 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; January 2000 (2000-01-01), BOUVIER-NAVE PIERRETTE ET AL: "Expression in yeast and tobacco of plant cDNAs encoding acyl CoA:diacylglycerol acyltransferase.", XP002148221, Database accession no. PREV200000103940 * |
DATABASE DBEST 19 September 1997 (1997-09-19), XP002148216 * |
DATABASE EMBL * |
DATABASE EMBL 10 June 1999 (1999-06-10), HILLS, M.J., ET AL.: "Arabidopsis thaliana mRNA for diacylglycerol O-acyltransferase", XP002148217 * |
DATABASE EMBL 17 April 2000 (2000-04-17), BROWN, A.P., ET AL.: "Brassica napus putative diacylglycerol acyltransferase mRNA, complete cds.", XP002148220 * |
DATABASE EMBL 23 December 1999 (1999-12-23) * |
DATABASE EMBL 26 July 1999 (1999-07-26), NYKIFORUK C.L., ET AL.: "Brassica napus putative diacylglycerol acyltransferase (DGAT1) mRNA,complete cds.", XP002148219 * |
DATABASE EMBL 30 June 1999 (1999-06-30), NYKIFORUK C.L., ET AL.: "Brassica napus putative diacylglycerol acyltransferase (DGAT2) mRNA, complete cds.", XP002148218 * |
DATABASE EMBL 4 November 1998 (1998-11-04), LIN, X., ET AL.: "Arabidopsis thaliana chromosome II section 113 of 255 of the complete sequence. Sequence from clones F27F23, F3P11.", XP002148214 * |
DATABASE EMBL 5 September 1996 (1996-09-05) * |
DATABASE GENBANK 16 May 1998 (1998-05-16), ROUNSLEY, S.D., ET AL.: "Arabidopsis thaliana chromosome II BAC F27F23 genomic sequence complete sequence", XP002148213 * |
DATABASE GENBANK 28 January 1999 (1999-01-28), LIN, X., ET AL.: "Arabidopsis thaliana chromosome II BAC F3P11 genomic sequence complete sequence.", XP002148215 * |
DATABASE GENPEPT * |
DATABASE GENPEPT 16 May 1998 (1998-05-16), ROUNSLEY, S.D., ET AL.: "putative acyl-CoA:cholesterol acyltransferase." * |
DATABASE GENPEPT 30 April 1999 (1999-04-30), ROUNSLEY, S.D., ET AL.: "sterol O-acyltransferase homolog F27F23.26 - Arabidopsis thaliana." * |
DATABASE STREMBL * |
EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 267, no. 1, January 2000 (2000-01-01), pages 85 - 96, ISSN: 0014-2956 * |
FRENTZEN M (REPRINT): "Acyltransferases from basic science to modified seed oils", FETT - LIPID,DE,WILEY-VCH VERLAG,WEINHEIM, vol. 100, no. 4/05, May 1998 (1998-05-01), pages 161 - 166, XP002122744, ISSN: 0931-5985 * |
HILLS M J ET AL: "DIACYLGLYCEROL ACYLTRANSFERASE - CLONING AND FUNCTIONAL EXPRESSION OF A CDNA FROM ARABIDOPSIS THALIANA", BIOCHEMICAL SOCIETY TRANSACTIONS,GB,COLCHESTER, ESSEX. 668TH MEETING OF THE BIOCHEMICAL SOCIETY; GLASGOW, SCOTLAND, UK; APRIL 7-9, 1999, vol. 27, no. 3, 1999, pages A124, XP000889768, ISSN: 0300-5127 * |
HOBBS, D.H., ET A.: "Cloning of a cDNA encoding diacylglycerol acyltransferase from Arabidopsis thaliana and its functional expression", FEBS LETTERS, vol. 452, June 1999 (1999-06-01), pages 145 - 149, XP002122747 * |
KATAVIC ET AL: "Alteration of seed fatty acid composition by an ethyl methanesulfonate-induced mutation in Arabidopsis thaliana affecting diacylglycerol acyltransferase activity", PLANT PHYSIOLOGY,US,AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS, ROCKVILLE, MD, no. 108, 1995, pages 399 - 409, XP002079129, ISSN: 0032-0889 * |
LITTLE ET AL: "Solubilization and characterization of diacylglycerol acyltransferase from microspore-derived cltures of oilseed rape", BIOCHEMICAL JOURNAL,GB,PORTLAND PRESS, LONDON, no. 304, 1994, pages 951 - 958, XP002079126, ISSN: 0264-6021 * |
WESELAKE ET AL: "Differential display of mRNA from oil-forming cell suspension cultures of Brassica napus", PHYSIOLOGY, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF PLANT LIPIDS,XX,XX, 1997, pages 357 - 359, XP002079130 * |
WILSON R F ET AL: "RECENT DEVELOPMENTS IN THE MOLECULAR BIOCHEMISTRY AND GENETICS OF DIACYGLYCEROL ACYLTRANSFERASE FROM SOYBEAN", SEED OILS FOR THE FUTURE,US,AOCS PRESS, CHAMPAIGN, IL, 1992, pages 116 - 135, XP000884791 * |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7862819B2 (en) | 2001-02-23 | 2011-01-04 | The J. David Gladstone Institutes | Diacylglycerol O-acyltransferase 2α (DGAT2α) |
US7045326B2 (en) | 2001-02-23 | 2006-05-16 | The Regents Of The University Of California | Mono- and diacylglycerol acyltransferases and methods of use thereof |
EP1543130A2 (fr) * | 2002-07-31 | 2005-06-22 | Monsanto Technology, LLC | Sequences d'acides nucleiques de la diacylglycerol acyltransferase et produits associes |
EP1543130A4 (fr) * | 2002-07-31 | 2006-07-12 | Monsanto Technology Llc | Sequences d'acides nucleiques de la diacylglycerol acyltransferase et produits associes |
US7939714B2 (en) | 2002-07-31 | 2011-05-10 | Monsanto Technology Llc | Diacylglycerol acyltransferase nucleic acid sequences and associated products |
US7417176B2 (en) | 2002-07-31 | 2008-08-26 | Monsanto Technology Llc | Diacylglycerol acyltransferase nucleic acid sequences and associated products |
US7935863B2 (en) | 2002-07-31 | 2011-05-03 | Monsanto Technology Llc | Diacylglycerol acyltransferase nucleic acid sequences and associated products |
EP1587359A4 (fr) * | 2003-01-08 | 2007-09-19 | Delta & Pine Land Co | Suppression de l'huile de graine servant a accroitre le rendement de macromolecules d'interet commercial |
EP1587359A2 (fr) * | 2003-01-08 | 2005-10-26 | Delta And Pine Land Company | Suppression de l'huile de graine servant a accroitre le rendement de macromolecules d'interet commercial |
US10260021B2 (en) | 2006-07-14 | 2019-04-16 | Commonwealth Scientific And Industrial Research Organisation | Rice plants and methods of producing rice grain |
US9351507B2 (en) | 2006-07-14 | 2016-05-31 | Commonwealth Scientific And Industrial Research Organisation | Method of preparing food using rice oil |
WO2009143401A3 (fr) * | 2008-05-23 | 2010-03-11 | E. I. Du Pont De Nemours And Company | Gènes dgat issus d'organismes oléagineux permettant une production accrue des lipides stockés dans les graines et une modification des profils d'acides gras dans les plantes oléagineuses |
US9187736B2 (en) | 2008-05-23 | 2015-11-17 | E I Du Pont De Nemours And Company | DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
US8153859B2 (en) | 2008-05-23 | 2012-04-10 | E.I. Du Pont De Nemours And Company | DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
US8399736B2 (en) | 2008-05-23 | 2013-03-19 | E.I. Du Pont De Nemours And Company | DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
EP2620502A3 (fr) * | 2008-05-23 | 2013-09-25 | E. I. du Pont de Nemours and Company | Gènes DGAT issus d'organismes oléagineux permettant une production accrue des lipides stockés dans les graines et une modification des profils d'acides gras dans les plantes oléagineuses |
EP2620501A3 (fr) * | 2008-05-23 | 2013-10-02 | E. I. du Pont de Nemours and Company | Gènes DGAT issus d'organismes oléagineux permettant une production accrue des lipides stockés dans les graines et une modification des profils d'acides gras dans les plantes oléagineuses |
EP2620500A3 (fr) * | 2008-05-23 | 2014-01-08 | E. I. du Pont de Nemours and Company | Gènes DGAT issus d'organismes oléagineux permettant une production accrue des lipides stockés dans les graines et une modification des profils d'acides gras dans les plantes oléagineuses |
US9790514B2 (en) | 2008-05-23 | 2017-10-17 | E I Du Pont De Nemours And Company | DGAT genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
US8921652B2 (en) | 2008-07-21 | 2014-12-30 | Commonwealth Scientific And Industrial Research Organisation | Vegetable oils and uses therefor |
US8716555B2 (en) | 2008-07-21 | 2014-05-06 | Commonwealth Scientific And Industrial Research Organisation | Cottonseed oil and uses |
US9057075B2 (en) | 2008-07-21 | 2015-06-16 | Commonwealth Scientific And Industrial Research Organisation | Cottonseed oil and uses |
US9127288B2 (en) | 2010-06-28 | 2015-09-08 | Commonwealth Scientific And Industrial Research Organisation | Methods of producing lipids |
US10925293B2 (en) | 2010-06-28 | 2021-02-23 | Commonwealth Scientific And Industrial Research Organisation | Methods of producing lipids |
US9499829B2 (en) | 2011-12-27 | 2016-11-22 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US11639507B2 (en) | 2011-12-27 | 2023-05-02 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US8735111B2 (en) | 2011-12-27 | 2014-05-27 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing hydrocarbon products |
US10246641B2 (en) | 2011-12-27 | 2019-04-02 | The Commonwealth Scientific And Industrial Research Organisation | Processes for producing hydrocarbon products |
US10246718B2 (en) | 2011-12-27 | 2019-04-02 | The Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US9061992B2 (en) | 2011-12-27 | 2015-06-23 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing hydrocarbon products |
US9512438B2 (en) | 2011-12-27 | 2016-12-06 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing hydrocarbon products |
US8809026B2 (en) | 2011-12-27 | 2014-08-19 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing lipids |
US10323209B2 (en) | 2012-04-25 | 2019-06-18 | Commonwealth Scientific And Industrial Research Organisation | High oleic acid oils |
US11124737B2 (en) | 2012-04-25 | 2021-09-21 | Commonwealth Scientific Andn Industrial Research Organisation | High oleic acid oils |
US10472587B2 (en) | 2014-07-07 | 2019-11-12 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing industrial products from plant lipids |
US11365369B2 (en) | 2014-07-07 | 2022-06-21 | Commonwealth Scientific And Industrial Research Organisation | Processes for producing industrial products from plant lipids |
US11814600B2 (en) | 2014-07-07 | 2023-11-14 | Nuseed Global Innnovation Ltd. | Process for producing industrial products from plant lipids |
US11859193B2 (en) | 2016-09-02 | 2024-01-02 | Nuseed Global Innovation Ltd. | Plants with modified traits |
Also Published As
Publication number | Publication date |
---|---|
EP1173583A1 (fr) | 2002-01-23 |
AU4703400A (en) | 2000-11-17 |
CA2372632C (fr) | 2011-02-15 |
CA2372632A1 (fr) | 2000-11-09 |
AU784352B2 (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2743384C2 (ru) | Способы получения промышленных продуктов из растительных липидов | |
EP0537178B1 (fr) | Sequence nucleotidique de gene de desaturase de stearoyle-acp de soja | |
US7008664B1 (en) | Method for improving the carcass quality of an animal | |
US5850026A (en) | Canola oil having increased oleic acid and decreased linolenic acid content | |
DE69113635T2 (de) | Nukleotidsequenzen der sojabohnen-acyl-acp-thioesterasegene. | |
AU2024201251A1 (en) | Plants with modified traits | |
CA2372632C (fr) | Acyltransferases de plantes | |
AU2017204957A1 (en) | Plants with modified traits | |
EP2414522B1 (fr) | Utilisation d'un promoteur spécifique de graine pour entraîner l'expression de odp1 dans des plantes oléagineuses crucifères pour augmenter la teneur en huile tout en conservant une germination normale | |
US6995301B1 (en) | Plant acyltransferases | |
US20150320002A1 (en) | Isolation and Use of FAD2 and FAE1 From Camelina | |
CA2547678A1 (fr) | Huile de colza possedant une teneur plus elevee en acide oleique et en acide linolenique | |
CA2784711A1 (fr) | Sequences de proteines de la famille des o-acyl transferases liees a la membrane vegetale et leurs utilisations pour modifier les compositions en acides gras | |
US6723895B2 (en) | Plants containing a cytosolic acetyl CoA-carboxylase nucleic acid | |
EP1283891B1 (fr) | Plantes contenant un acide nucleique d'acetyl coa-carboxylase cytosolique | |
AU2004201052A1 (en) | Genes for desaturases to alter lipid profiles in corn | |
AU2007229342A1 (en) | Genes for desaturases to alter lipid profiles in corn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2372632 Country of ref document: CA Ref country code: CA Ref document number: 2372632 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000928864 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 47034/00 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000928864 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |